Evidence Base

The science behind SnoozeSync

SnoozeSync teaches the same Cognitive Behavioral Therapy for Insomnia (CBT-I) techniques recommended by the American College of Physicians, the American Academy of Sleep Medicine, and the European Sleep Research Society. The peer-reviewed studies below are the foundation our protocol is built on.

Clinical Practice Guidelines

Three major medical bodies have published clinical practice guidelines naming CBT-I as the first-line treatment for chronic insomnia in adults — recommended before sedative-hypnotic medication.

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians (2016)
Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 165(2):125–133. Open paper →
Recommendation: "ACP recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder." Grade: strong recommendation, moderate-quality evidence.
Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017)
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults — American Academy of Sleep Medicine
Journal of Clinical Sleep Medicine, 13(2):307–349. Open paper →
Position: The AASM names CBT-I as the standard of care and recommends pharmacotherapy only as adjunct to or after a failed trial of CBT-I.
Riemann D, Baglioni C, Bassetti C, Bjorvatn B, et al. (2017)
European guideline for the diagnosis and treatment of insomnia
Journal of Sleep Research, 26(6):675–700. Open paper →
Recommendation: "Cognitive behavioral therapy for insomnia is recommended as the first-line treatment for chronic insomnia in adults of any age." Highest grade of recommendation (A).

Foundational Trials

The randomized controlled trials that established CBT-I as a durable, drug-free treatment for chronic insomnia.

Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE (2001)
Cognitive Behavioral Therapy for Treatment of Chronic Primary Insomnia: A Randomized Controlled Trial
JAMA, 285(14):1856–1864. Open paper →
Finding: CBT-I produced significantly larger improvements than relaxation therapy or placebo across every primary sleep measure — including sleep efficiency, sleep latency, and wake after sleep onset.
Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, Bastien C, Baillargeon L (2009)
Cognitive Behavioral Therapy, Singly and Combined With Medication, for Persistent Insomnia: A Randomized Controlled Trial
JAMA, 301(19):2005–2015. Open paper →
Finding: CBT-I alone produced more durable remission at 6-month follow-up than CBT-I + medication. Adding zolpidem to CBT-I did not improve long-term outcomes.
Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, Buysse DJ (2002)
Comparative Meta-Analysis of Pharmacotherapy and Behavior Therapy for Persistent Insomnia
American Journal of Psychiatry, 159(1):5–11. Open paper →
Finding: Behavior therapy and pharmacotherapy produced comparable short-term improvements in sleep latency and total sleep time, but only behavior therapy effects persisted at follow-up.
Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D (2015)
Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-Analysis
Annals of Internal Medicine, 163(3):191–204. Open paper →
Finding: Across 20 RCTs (n=1,162) CBT-I produced clinically significant improvements in sleep onset latency (−19 min), wake after sleep onset (−26 min), and sleep efficiency (+10%) versus controls.

Digital CBT-I Trials

SnoozeSync is a digitally-delivered CBT-I product. The studies below establish that digital CBT-I — when it implements the full protocol — is non-inferior to in-person therapy for the typical patient.

Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, Brown JS (2012)
A Randomized, Placebo-Controlled Trial of Online Cognitive Behavioral Therapy for Chronic Insomnia Disorder Delivered via an Automated Media-Rich Web Application
Sleep, 35(6):769–781. Open paper →
Finding: An unaccompanied online CBT-I program (Sleepio) produced significantly larger improvements in sleep efficiency and Insomnia Severity Index than an imagery-relaxation placebo. First major RCT validating fully-automated digital CBT-I.
Ritterband LM, Thorndike FP, Ingersoll KS, Lord HR, Gonder-Frederick L, Frederick C, Quigg MS, Cohn WF, Morin CM (2017)
Effect of a Web-Based Cognitive Behavior Therapy for Insomnia Intervention With 1-Year Follow-up — A Randomized Clinical Trial
JAMA Psychiatry, 74(1):68–75. Open paper →
Finding: The SHUTi web-based CBT-I program produced improvements in insomnia severity that were maintained at 1-year follow-up. 56.6% of treated participants were in clinical remission versus 17.0% of controls.
Soh HL, Ho RC, Ho CS, Tam WW (2020)
Efficacy of digital cognitive behavioural therapy for insomnia: A meta-analysis of randomised controlled trials
Sleep Medicine, 75:315–325. Open paper →
Finding: Across 33 RCTs (n=5,946), digital CBT-I produced moderate-to-large effects on insomnia severity, sleep efficiency, and sleep onset latency that persisted at follow-up.

CBT-I in Comorbid Conditions

CBT-I improves outcomes not just for primary insomnia but for insomnia comorbid with depression, anxiety, and chronic pain — three of the most common reasons patients present with sleep complaints.

Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T (2008)
Cognitive Behavioral Therapy for Insomnia Enhances Depression Outcome in Patients With Comorbid Major Depressive Disorder and Insomnia
Sleep, 31(4):489–495. Open paper →
Finding: Adding CBT-I to escitalopram improved both insomnia and depression remission rates compared to escitalopram alone in patients with comorbid MDD and insomnia.
Wu JQ, Appleman ER, Salazar RD, Ong JC (2015)
Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis
JAMA Internal Medicine, 175(9):1461–1472. Open paper →
Finding: Across 37 RCTs, CBT-I produced robust improvements in insomnia and modest improvements in the comorbid condition itself (depression, anxiety, pain).

How SnoozeSync Implements This Evidence

SnoozeSync's 6-week curriculum follows the same Stimulus Control + Sleep Restriction + Cognitive Restructuring + Sleep Hygiene protocol used in the trials above.

Stimulus Control (Weeks 1–2): the bed is for sleep only; get out of bed when awake more than 20 minutes; same wake time every day. Based on Bootzin's original 1972 protocol and validated in dozens of subsequent trials.

Sleep Restriction Therapy (Weeks 2–4): the suggested time-in-bed window is recalculated from the user's 7-day rolling sleep efficiency as diary entries are logged. Window expands when SE crosses 85% for 5 consecutive nights, contracts below 80%. Validated by Spielman 1987 and refined by Edinger 2001.

Cognitive Restructuring (Weeks 3–5): the AI Sleep Coach guides users through identifying and reframing the worry-driven thoughts that fuel hyperarousal at night. Based on Morin's CBT-I treatment manual (1993).

Outcome measurement: Sleep Efficiency (Total Sleep Time ÷ Time In Bed × 100) is the primary outcome the app tracks. The clinical target is ≥85% averaged over a 7-day window — the same threshold used in the trials referenced above.

For Clinicians

Healthcare providers can request a clinical evaluation account or refer patients to the program by contacting support@snoozesync.com. Patients may export their sleep diary, efficiency trends, and CBT-I progress as a PDF directly from within the app and share with their physician.

SnoozeSync is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified physician for sleep complaints, especially if you have any of the following: loud snoring or witnessed apneas (possible obstructive sleep apnea); restless legs; suicidal ideation; bipolar disorder or epilepsy (sleep restriction may need physician supervision); or current use of sedative-hypnotic medication.